Puente, A, Turón, F, Martínez, J, Fortea, JI, Guerra, MH, Alvarado, E, Pons, M, Magaz, M, Llop, E, Alvarez-Navascués, C, Navarrete, AA, Berenguer, M, Masnou, H, Bañares, R, Casado, M, Ampuero, J, Rios, J, Saavedra, C, Blasi, A, Lisman, T, Figuero, CR, Huelin, P, Tellez, L, Arráez, DM, Rodriguez, M, Aguilera, V, Loste, MTA, Baiges, A, Hernandez-Gea, V, Perelló, C, Calleja, JL, Genescà, J, Villanueva, C, Gonzalez-Alayón, C, Albillos, A, Crespo, J, Garcia-Pagán, JC. Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study. JOURNAL OF HEPATOLOGY. 2025; 83(5)DOI:10.1016/j.jhep.2025.06.035. PMID:40691992. IF:33.000(Q1/1D).

Martinez-Brocca, MA, Bellido, V, Cardona-Hernandez, R, Castaño, L, Conget, I, Fernández, A, Gila, ALG, Leiva-Gea, I, Mauricio, D. Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:10.1016/j.endinu.2025.501639. PMID:41111054. IF:1.800(Q3/8D).

Aulinas, A, Lawson, EA. Oxytocin in hypopituitarism: What do we know?. Endocrinologia Diabetes y Nutricion. 2025; 72(9)DOI:. PMID:41173566. IF:1.800(Q3/8D).

Giordano, A, Bastón-Rey, I, Madero, L, Brunet-Mas, E, Calafat, M. Unraveling the gut-fat-inflammation connection in Crohn's disease: A path to new therapeutic targets?. Gastroenterologia y Hepatologia. 2025; 48(9)DOI:10.1016/j.gastrohep.2025.502466. PMID:40378950. IF:1.900(Q3/7D).